Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Cancer Mortality Rate (per 100,000 Population), 2000 & 2010
Figure 5-1: Pharmaceutical Market (Billion US$), 2010-2014
Figure 5-2: Share of Generics in Pharmaceutical Market (2011)
Figure 5-3: Pharmaceutical Sales by Facility (%), 2009
Figure 6-1: Healthcare Expenditure (Billion US$), 2010 & 2015
Figure 6-2: Percentage Distribution of Healthcare Expenditure by Diseases for Population Aged below 65 (2008)
Figure 6-3: Percentage Distribution of Healthcare Expenditure by Diseases for Population Aged 65 and Above (2008)
Figure 6-4: Share of Generic Drugs in Pharmaceuticals Market w.r.t Developed Countries (2009)
Figure 6-5: Generic Drugs Market (Billion US$), 2010-2014
Figure 6-6: Market Share of Generic Drugs Manufacturers (2010)
Figure 6-7: Generic Drugs Market by Segment (%), 2009
Figure 6-8: Generic Drugs Market by Medical Institution (%), 2008 & 2009
Figure 6-9: Number of DPC Hospitals (FY 2007 to FY 2010)
Figure 6-10: Generic Drugs Market by Distribution Channel (%), 2008 & 2009
Figure 11-1: Sawai Pharmaceutical - Sales by Therapeutic Category (%), FY 2010
Figure 11-2: Towa Pharmaceutical - Sales by Therapeutic Category (%), Mar 2011

List of Tables:

Table 3-1: Recent Industry Activities in Cancer Generics
Table 4-1: Demographic Characteristics (2010 & 2015)
Table 6-1: Recent Generic Drugs Launch of Key Players (2011)
Table 8-1: Application Fee for Manufacturing and Marketing of Generics (JPY)
Table 9-1: Key Measures for Generic Drugs Promotion
Table 10-1: Patent Expiry of Key Drugs in Japan (2012-2015)